Medicine recalls
|
| |
| Recall of “Tarceva Tablet 100mg” |
| |
The Department of Health (DH) today (October 15) endorsed a licensed drug wholesaler, Roche Hong Kong Limited (Roche), to recall a batch (batch number: M1026MC) of Tarceva Tablet 100mg (Hong Kong registration number: HK-57440) from the market as a precautionary measure because incorrect batch number was printed on the blister foils of the batch of product.
The DH received notification from Roche that a customer found an incorrect batch number (M1626MC) appeared on the blister foils of a recent delivery of the product. According to Roche, the product was manufactured and packed by an overseas manufacturer and has been supplied to two private hospitals and a private clinic as well as re-exported to Macao. As a precautionary measure, Roche is voluntarily recalling the batch from the market.
The above product containing erlotinib and is a prescription medicine used for treatment of lung cancer and pancreatic cancer.
So far, the DH has not received any adverse reaction reports in connection with the affected product.
The wholesaler has set up a hotline (2895 9531) to answer related enquiries. The DH will closely monitor the recall.
Patients who have used the above product should not stop medication by their own but should seek advice from their attending doctor if in doubt.
Ends/Friday, 15 October, 2021
|
| |
